Bellerophon Therapeutics Inc (BLPH)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-10-16 | 2023-10-13 | S Sale |
Puissance Capital Management LP Large shareholder |
1,076,841
-100.0%
0.10USD 111,776 |
1,076,841 -100.0% | 0.10 | USD 111,776 | |
| 2023-06-07 | 2023-06-07 | S Sale |
Puissance Life Science Opportunities Fund VI Large shareholder |
134,421
-11.1%
0.83USD 111,569 |
134,421 -11.1% | 0.83 | USD 111,569 | |
| 2023-05-22 | 2023-05-18 | S Sale |
VP Reg. Affairs & Quality Officer |
9,455
-84.6%
10.00USD 94,550 |
9,455 -84.6% | 10.00 | USD 94,550 | |
| 2023-05-19 | 2023-05-18 | S Sale |
Puissance Life Science Opportunities Fund VI Large shareholder |
560,000
-31.6%
9.46USD 5,297,600 |
560,000 -31.6% | 9.46 | USD 5,297,600 | |
| 2021-03-22 | 2021-03-18 | S Sale |
New Mountain Investments II, LLC Large shareholder |
400,000
-39.6%
5.48USD 2,192,000 |
400,000 -39.6% | 5.48 | USD 2,192,000 | |
| 2020-09-14 | 2020-09-10 | B Purchase |
Chief Medical Officer Officer |
4,000
+inf%
10.18USD 40,708 |
4,000 +inf% | 10.18 | USD 40,708 | |
| 2020-06-09 | 2020-06-08 | B Purchase | Non-Executive Director Large shareholder |
2,600
+4.5%
12.87USD 33,454 |
2,600 +4.5% | 12.87 | USD 33,454 | |
| 2020-06-09 | 2020-06-05 | B Purchase | Non-Executive Director Large shareholder |
4,986
+9.3%
12.72USD 63,442 |
4,986 +9.3% | 12.72 | USD 63,442 | |
| 2019-11-25 | 2019-11-25 | B Purchase | Non-Executive Director Large shareholder |
7,193
+1.2%
0.39USD 2,774 |
7,193 +1.2% | 0.39 | USD 2,774 | |
| 2019-11-25 | 2019-11-22 | B Purchase | Non-Executive Director Large shareholder |
1,050
+0.2%
0.37USD 394 |
1,050 +0.2% | 0.37 | USD 394 | |
| 2019-11-25 | 2019-11-21 | B Purchase | Non-Executive Director Large shareholder |
200
+0.0%
0.37USD 74 |
200 +0.0% | 0.37 | USD 74 | |
| 2019-10-28 | 2019-10-28 | S Sale | Large shareholder |
333,010
-4.9%
0.44USD 146,091 |
333,010 -4.9% | 0.44 | USD 146,091 | |
| 2019-10-28 | 2019-10-28 | S Sale | Large shareholder |
333,010
-4.9%
0.44USD 146,091 |
333,010 -4.9% | 0.44 | USD 146,091 | |
| 2019-10-28 | 2019-10-25 | S Sale | Large shareholder |
56,242
-0.8%
0.45USD 25,511 |
56,242 -0.8% | 0.45 | USD 25,511 | |
| 2019-10-28 | 2019-10-25 | S Sale | Large shareholder |
56,242
-0.8%
0.45USD 25,511 |
56,242 -0.8% | 0.45 | USD 25,511 | |
| 2019-10-28 | 2019-10-24 | S Sale | Large shareholder |
704,595
-9.4%
0.50USD 353,354 |
704,595 -9.4% | 0.50 | USD 353,354 | |
| 2019-10-28 | 2019-10-24 | S Sale | Large shareholder |
704,595
-9.4%
0.50USD 353,354 |
704,595 -9.4% | 0.50 | USD 353,354 | |
| 2019-06-14 | 2019-06-12 | B Purchase | Large shareholder |
50,000
+9.4%
0.64USD 31,905 |
50,000 +9.4% | 0.64 | USD 31,905 | |
| 2019-05-24 | 2019-05-22 | B Purchase | Large shareholder |
27,500
+5.4%
0.60USD 16,533 |
27,500 +5.4% | 0.60 | USD 16,533 | |
| 2019-05-22 | 2019-05-21 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+1.0%
0.60USD 2,975 |
5,000 +1.0% | 0.60 | USD 2,975 |